Point72 Hong Kong LTD Evolus, Inc. Transaction History

Point72 Hong Kong LTD

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $36,480 - $50,544	4,800 New	4,800 $50,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $22,705 - $40,144	2,926 New	2,926 $24,000
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $23,945 - $32,661	-2,343 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $11,097 - $25,044	2,126 Added 979.72%	2,343 $26,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $3,173 - $4,952	-591 Reduced 73.14%	217 $1,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $1,037 - $1,927	141 Added 21.14%	808 $6,000
Q2 2021 Aug 16, 2021	SELL	$8.42 - $13.96 $11,265 - $18,678	-1,338 Reduced 66.73%	667 $8,000
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $3,241 - $16,724	1,013 Added 102.12%	2,005 $26,000
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $680 - $1,127	-233 Reduced 19.02%	992 $3,000
Q3 2020 Nov 16, 2020	BUY	$3.03 - $5.48 $412 - $745	136 Added 12.49%	1,225 $5,000
Q2 2020 Aug 14, 2020	SELL	$3.53 - $6.17 $4,200 - $7,342	-1,190 Reduced 52.22%	1,089 $6,000
Q1 2020 May 15, 2020	BUY	$3.53 - $12.21 $7,871 - $27,228	2,230 Added 4551.02%	2,279 $9,000
Q4 2019 Feb 14, 2020	BUY	$11.58 - $17.37 $567 - $851	49 New	49 $1,000
Q3 2019 Nov 14, 2019	SELL	$13.91 - $19.87 $1,780 - $2,543	-128 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.19 - $28.36 $1,688 - $3,630	128 New	128 $2,000
Q1 2019 May 15, 2019	SELL	$12.43 - $28.91 $1,379 - $3,209	-111 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$10.57 - $19.29 $31,340 - $57,194	-2,965 Reduced 96.39%	111 $1,000
Q3 2018 Nov 14, 2018	BUY	$17.31 - $29.82 $53,245 - $91,726	3,076 New	3,076 $57,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.